BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 31226655)

  • 1. Jietacins, azoxy natural products, as novel NF-κB inhibitors: Discovery, synthesis, biological activity, and mode of action.
    Watanabe M; Sugawara A; Noguchi Y; Hirose T; Ōmura S; Sunazuka T; Horie R
    Eur J Med Chem; 2019 Sep; 178():636-647. PubMed ID: 31226655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Jietacins, azoxy antibiotics with potent nematocidal activity: Design, synthesis, and biological evaluation against parasitic nematodes.
    Sugawara A; Kubo M; Hirose T; Yahagi K; Tsunoda N; Noguchi Y; Nakashima T; Takahashi Y; Welz C; Mueller D; Mertens C; Koebberling J; Ōmura S; Sunazuka T
    Eur J Med Chem; 2018 Feb; 145():524-538. PubMed ID: 29335213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The inhibition of TNF-alpha-induced NF-kappaB activation by marine natural products.
    Folmer F; Jaspars M; Solano G; Cristofanon S; Henry E; Tabudravu J; Black K; Green DH; Küpper FC; Aalbersberg W; Feussner K; Dicato M; Diederich M
    Biochem Pharmacol; 2009 Sep; 78(6):592-606. PubMed ID: 19445900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of antitumor ursolic acid long-chain diamine derivatives as potent inhibitors of NF-κB.
    Jiang W; Huang RZ; Zhang J; Guo T; Zhang MT; Huang XC; Zhang B; Liao ZX; Sun J; Wang HS
    Bioorg Chem; 2018 Sep; 79():265-276. PubMed ID: 29778798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of new inhibitors against both NF-κB and osteoclastogenesis from in-house library with α, β-unsaturated-enone fragment.
    Zhao C; Huang D; Li R; Xu J; Gu Q; Xu J
    Bioorg Chem; 2019 Jun; 87():638-646. PubMed ID: 30947099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, and biological evaluation of benzofuran- and 2,3-dihydrobenzofuran-2-carboxylic acid N-(substituted)phenylamide derivatives as anticancer agents and inhibitors of NF-κB.
    Choi M; Jo H; Park HJ; Sateesh Kumar A; Lee J; Yun J; Kim Y; Han SB; Jung JK; Cho J; Lee K; Kwak JH; Lee H
    Bioorg Med Chem Lett; 2015 Jun; 25(12):2545-9. PubMed ID: 25953156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Marine natural products as targeted modulators of the transcription factor NF-kappaB.
    Folmer F; Jaspars M; Dicato M; Diederich M
    Biochem Pharmacol; 2008 Feb; 75(3):603-17. PubMed ID: 17919455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of Protein-Protein Interaction Inhibitors by Integrating Protein Engineering and Chemical Screening Platforms.
    Maculins T; Garcia-Pardo J; Skenderovic A; Gebel J; Putyrski M; Vorobyov A; Busse P; Varga G; Kuzikov M; Zaliani A; Rahighi S; Schaeffer V; Parnham MJ; Sidhu SS; Ernst A; Dötsch V; Akutsu M; Dikic I
    Cell Chem Biol; 2020 Nov; 27(11):1441-1451.e7. PubMed ID: 32726587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The natural product bergenin ameliorates lipopolysaccharide-induced acute lung injury by inhibiting NF-kappaB activition.
    Yang S; Yu Z; Wang L; Yuan T; Wang X; Zhang X; Wang J; Lv Y; Du G
    J Ethnopharmacol; 2017 Mar; 200():147-155. PubMed ID: 28192201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-phenylsulfonyl-3,5-bis(arylidene)-4-piperidone derivatives as activation NF-κB inhibitors in hepatic carcinoma cell lines.
    Li N; Xin WY; Yao BR; Cong W; Wang CH; Hou GG
    Eur J Med Chem; 2018 Jul; 155():531-544. PubMed ID: 29909338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and nematocidal activities of jietacin A and its analogs.
    Tsuzuki K; Yan FS; Otoguro K; Omura S
    J Antibiot (Tokyo); 1991 Jul; 44(7):774-84. PubMed ID: 1880067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rugulactone derivatives act as inhibitors of NF-κB activation and modulates the transcription of NF-κB dependent genes in MDA-MB-231cells.
    Mohapatra DK; Reddy DS; Ramaiah MJ; Ghosh S; Pothula V; Lunavath S; Thomas S; Valli SN; Bhadra MP; Yadav JS
    Bioorg Med Chem Lett; 2014 Mar; 24(5):1389-96. PubMed ID: 24508135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural products as targeted modulators of the nuclear factor-kappaB pathway.
    Bremner P; Heinrich M
    J Pharm Pharmacol; 2002 Apr; 54(4):453-72. PubMed ID: 11999122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological evaluation of pharbinilic acid and derivatives as NF-κB pathway inhibitors.
    Annand JR; Bruno PA; Mapp AK; Schindler CS
    Chem Commun (Camb); 2015 May; 51(43):8990-3. PubMed ID: 25932702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of NF-κB-dependent HIV-1 replication by the marine natural product bengamide A.
    Tietjen I; Williams DE; Read S; Kuang XT; Mwimanzi P; Wilhelm E; Markle T; Kinloch NN; Naphen CN; Tenney K; Mesplède T; Wainberg MA; Crews P; Bell B; Andersen RJ; Brumme ZL; Brockman MA
    Antiviral Res; 2018 Apr; 152():94-103. PubMed ID: 29476895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of angular naphthopyrones from the Philippine echinoderm Comanthus species as inhibitors of the NF-κB signaling pathway.
    Chovolou Y; Ebada SS; Wätjen W; Proksch P
    Eur J Pharmacol; 2011 Apr; 657(1-3):26-34. PubMed ID: 21296074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting of nuclear factor kappaB Pathways by dehydroxymethylepoxyquinomicin, a novel inhibitor of breast carcinomas: antitumor and antiangiogenic potential in vivo.
    Matsumoto G; Namekawa J; Muta M; Nakamura T; Bando H; Tohyama K; Toi M; Umezawa K
    Clin Cancer Res; 2005 Feb; 11(3):1287-93. PubMed ID: 15709200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of lesser known flavones as inhibitors of NF-κB signaling in MDA-MB-231 breast cancer cells--A SAR study.
    Amrutha K; Nanjan P; Shaji SK; Sunilkumar D; Subhalakshmi K; Rajakrishna L; Banerji A
    Bioorg Med Chem Lett; 2014 Oct; 24(19):4735-4742. PubMed ID: 25190466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of nuclear translocation of nuclear factor-kappaB despite lack of functional IkappaBalpha protein overcomes multiple defects in apoptosis signaling in human B-cell malignancies.
    Thomas RK; Sos ML; Zander T; Mani O; Popov A; Berenbrinker D; Smola-Hess S; Schultze JL; Wolf J
    Clin Cancer Res; 2005 Nov; 11(22):8186-94. PubMed ID: 16299251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of natural nuclear factor-kappa B inhibitors on anticancer drug efflux transporter human P-glycoprotein.
    Nabekura T; Hiroi T; Kawasaki T; Uwai Y
    Biomed Pharmacother; 2015 Mar; 70():140-5. PubMed ID: 25776492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.